Inventor
HOWBERT J JEFFRY
US40 patents
⚠️ This page may combine multiple inventors who share the name “HOWBERT J JEFFRY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LILLY CO ELI
26 patentsUS5567714AOct 22, 1996
Methods of treating obesity by inhibiting physiological conditions associated with an excess of neuropeptide Y
LILLY CO ELI60 citations96
US5684033ANov 4, 1997
Non-peptide tachykinin receptor antagonists
LILLY CO ELI30 citations92
US5670499ASep 23, 1997
Non-peptide tachykinin receptor antagonists
LILLY CO ELI28 citations92
US5663192ASep 2, 1997
Heterocyclic neuropeptide Y receptor antagonists
LILLY CO ELI23 citations92
US5576337ANov 19, 1996
Method of treating anxiety by inhibiting physiological conditions associated with an excess of neuropeptide Y
LILLY CO ELI23 citations92
US5504094AApr 2, 1996
Use of bengothiophenls to treat pain due to an excess of neuropeptide y
LILLY CO ELI26 citations92
US5491140AFeb 13, 1996
Naphthyl tachykinin receptor antagonists to treat physiological conditions
LILLY CO ELI29 citations92
US5354778AOct 11, 1994
Antitumor compositions and methods of treatment
LILLY CO ELI20 citations92
US5565568AOct 15, 1996
2-acylaminopropanamides as tachykinin receptor antagonists
LILLY CO ELI37 citations91
US5216026AJun 1, 1993
Antitumor compositions and methods of treatment
LILLY CO ELI10 citations74
US6727255B1Apr 27, 2004
Piperidinyl and piperazinyl tachykinin receptor antagonists
LILLY CO ELI6 citations73
US6562862B1May 13, 2003
Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
LILLY CO ELI4 citations73
US6403577B1Jun 11, 2002
Hexamethyleneiminyl tachykinin receptor antagonists
LILLY CO ELI5 citations73
US6147115ANov 14, 2000
Antitumor compositions and methods of treatment
LILLY CO ELI14 citations73
US5567715AOct 22, 1996
Methods of treating depression by inhibiting physiological conditions associated with an excess of neuropeptide Y
LILLY CO ELI9 citations73
US5234955AAug 10, 1993
Antitumor compositions and methods of treatment
LILLY CO ELI5 citations73
US5594028AJan 14, 1997
Anti-tumor method and compounds
LILLY CO ELI5 citations72
US5565494AOct 15, 1996
Antitumor compositions and methods of treatment
LILLY CO ELI7 citations72
US5302724AApr 12, 1994
Antitumor compositions and methods of treatment
LILLY CO ELI17 citations71
US5399565AMar 21, 1995
Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations therof
LILLY CO ELI19 citations70
US6869957B1Mar 22, 2005
Non-peptide tachykinin receptor antagonists
LILLY CO ELI6 citations62
US6175013B1Jan 16, 2001
Imidazolinyl tachykinin receptor antagonists
LILLY CO ELI3 citations62
US5545641AAug 13, 1996
Methods of inhibiting physiological conditions associated with an excess of bradykinin
LILLY CO ELI4 citations62
US5643926AJul 1, 1997
Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations thereof
LILLY CO ELI2 citations61
US5300514AApr 5, 1994
Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations thereof
LILLY CO ELI4 citations61
US5514675AMay 7, 1996
Naphthyl bradykinin receptor antagonists
LILLY CO ELI1 citations52
QIAGEN GENOMICS INC
4 patentsUS6623928B2Sep 23, 2003
Methods and compositions for determining the sequence of nucleic acid molecules
QIAGEN GENOMICS INC120 citations99
US6312893B1Nov 6, 2001
Methods and compositions for determining the sequence of nucleic acid molecules
QIAGEN GENOMICS INC354 citations99
US6613508B1Sep 2, 2003
Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques
QIAGEN GENOMICS INC235 citations98
US6815212B2Nov 9, 2004
Methods and compositions for enhancing sensitivity in the analysis of biological-based assays
QIAGEN GENOMICS INC62 citations96
OPERON BIOTECHNOLOGIES INC
3 patentsUS7052846B2May 30, 2006
Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques
OPERON BIOTECHNOLOGIES INC20 citations92
US7642344B2Jan 5, 2010
Methods and compositions for determining the sequence of nucleic acid molecules
OPERON BIOTECHNOLOGIES INC9 citations83
US7247434B2Jul 24, 2007
Methods and compositions for determining the sequence of nucleic acid molecules
OPERON BIOTECHNOLOGIES INC5 citations73
HOWBERT J JEFFRY
3 patentsUS8242106B2Aug 14, 2012
Toll-like receptor agonist formulations and their use
HOWBERT J JEFFRY10 citations80
US8314090B2Nov 20, 2012
Methods of synthesis of benzazepine derivatives
HOWBERT J JEFFRY6 citations75
US9216192B2Dec 22, 2015
Toll-like receptor agonist formulations and their use
HOWBERT J JEFFRY1 citations48